Volume 18, Number 8—August 2012
Dispatch
Severe Human Granulocytic Anaplasmosis Transmitted by Blood Transfusion
Table 2
Date, 2010 |
Patient
|
Donor
|
|||||
---|---|---|---|---|---|---|---|
PCR | IFA | Remarks | PCR | IFA | Remarks | ||
May 12† | – | – | 118 d before index donation | ||||
Aug 28–29 | ND | ND | Febrile illness | ||||
Sep | |||||||
7† |
+ | >1,024 | Index donation | ||||
15 |
– | – | Transfusion | ||||
25 |
ND | ND | Onset of febrile illness | ||||
Oct | |||||||
1 |
+‡ | – | Treatment with doxycycline Oct 1–14 | ||||
4 |
+ | 128 | |||||
6 |
+ | 512 | |||||
9 |
+ | ND | |||||
10 |
– | ND | |||||
12 |
– | 512 | |||||
19 |
ND | 512 | |||||
20 |
– | >1,024 | 43 d after index donation | ||||
Nov 23 | ND | >1,024 | No reports of problems |
*Results for IFA are shown in titers. IFA, immunofluorescence assay; ND, not done; –, negative; +, positive.
†Retrospective testing of stored blood specimen.
‡DNA detected in stored bone marrow–biopsy specimen.
Page created: July 19, 2012
Page updated: July 19, 2012
Page reviewed: July 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.